Week in Review
ChanRx Corp. raised $5.5 million in a Series A round for its atrial fibrillation drug.
Coronado Biosciences Inc.'s stock debuted on the Over The Counter Bulletin Board at $11 after taking a Form 10 path to get public.
Portola Pharmaceuticals Inc. raised $89 million in a Series D financing.
Excaliard Pharmaceuticals Inc. is being acquired by Pfizer Inc. (no terms).
Gilead Sciences Inc.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST